The authors describe four thromboembolic accidents in vitro fertilizat
ions. These accidents were not associated with an ovarian hyperstimula
tion syndrome. However, all patients presented a risk factor of thromb
osis. The relationship between endocrine treatment and the occurrence
of side effects is discussed.